Center Information1123 N. Main Avenue
San Antonio, Texas 78212
Phone: (210) 223-4444
Study Recruitment – Deborah Kotara, RN
Business Development – Deborah Kotara RN
Currently Enrolling Trials
Inspired by Dr. Pergola, Clinical Advancement Center was originally founded as the Research Division of Renal Associates, PA in 2005. In 2013, it became the Clinical Advancement Center and remains affiliated with Renal Associates, PA.
The Clinical Advancement Center, PLLC is the leading research site in San Antonio, Texas dedicated to the performance of high-quality clinical research of renal diseases.
Our team is highly experienced in the conduct of clinical research studies, offering a wealth of expertise for the benefit of our trial participants and clients. The Clinical Advancement Center, PLLC, team is experienced, intelligent, and driven by their innovative passion to advance medical science for the betterment of the community.
At the Clinical Advancement Center, PLLC, the focus is on quality which is the result of a unified vision and tenacious pursuit of excellence by our team in cooperation with our pharmaceutical and biotech partners.
Our site has over 18 years of experience in phase I-IV clinical research studies. We are consistently one of the top enrollers for the studies we have participated in. We have successfully completed several FDA audits without the issuance of a FDA Form 483. Our study coordinators and research staff are fully dedicated to research and focused on the care and well being of our participant volunteers.
The Clinical Advancement Center, PLLC, has a progressive culture of innovation, and quality. Leading that innovative drive is the ability to adapt to change. In the post COVID-19 landscape adaptability is crucial. As one of the first sites to go fully electronic, we’ve embraced that challenge and leveraged the use of e-source technology to lead the way forward in this new paradigm. A truly successful trial can only be achieved through collaboration where Sponsor/CRO and site work towards a common vision. As an expert in nephrology and pharmacology, Dr. Pergola actively participates as a scientific advisor for Sponsors and frequently consults on drug/protocol development. Dr. Pergola regularly presents and lectures at industry meetings and conferences. As an industry thought leader, Dr. Pergola is well published and is actively sought after to write and contribute to various scientific and medical publications. At the Clinical Advancement Center, PLLC, the focus is on quality which is the result of a unified vision and tenacious pursuit of excellence by our team in cooperation with our pharmaceutical and biotech partners. It is simply not enough to just meet enrollment goals, you must produce high quality data that can withstand the scrutiny of review and inspection. As a high enrolling site, the Clinical Advancement Center, PLLC, has been through several agency audits with no citations which is a testament to our team and culture.
Since its establishment in 2005, the Clinical Advancement Center, PLLC has been a stalwart fixture in the nephrology clinical trial community, conducting phase I-IV studies. Study indications include:
- Chronic Kidney Disease
- Diabetic Nephropathy
- IgA Nephropathy
- Dialysis Vascular Devices
- Heart Failure
- Bone and Mineral disorders
All of our equipment is calibrated to manufacturer specifications and inspected annually by a local reputable vendor.
In 2018 the Clinical Advancement Center, PLLC began the process of adopting and implementing e-technology to the conduct of our clinical trials. Today, we are fully electronic, utilizing Real Time CTMS for e-source and e-regulatory management as well as for recruitment and billing. The Clinical Advancement Center, PLLC also uses Vestigo for investigational product management. Both systems are 21 CFR Part 11 compliant and allow for remote access by assigned monitors/auditors.
Dr. Pergola has been conducting clinical research since 2005. He earned his medical degree (M.D.) from the Universidad del Salvador, Buenos Aires, Argentina in 1988. He completed his Doctor of Philosophy degree (PhD.) from the University of Kansas Medical Center, Dept. of Pharmacology, Toxicology and Therapeutics in 1991. Dr. Pergola completed his post graduate training at University of Texas Health Science Center at San Antonio (UTHSCSA) with board certifications in internal medicine and nephrology. Dr. Pergola has also been a specialist in clinical hypertension. In 1999 he joined the faculty at UTHSCSA as Assistant Professor of Medicine where he remained until May 2005 when he joined Renal Associates. Upon joining Renal Associates, PA he established the Research Division which became Clinical Advancement Center, PLLC (CAC) on January 1, 2013. As the Research Director and Principal Investigator for CAC, Dr. Pergola has broad acumen of clinical research experience and is passionate about providing clinical research opportunities to his patient’s treatment paradigm.
Under the leadership of Pablo E. Pergola, MD., PhD, Director of Research, and Letti Hudson, RN, Clinical Site Manager, our staff is dedicated to providing rapid enrollment, timely and accurate data collection and excellent patient care. Our staff highly trained and fully dedicated to research with experience in various indications.
Our site has experience using Advarra IRB, WCG IRB and Alpha IRB